Acute Lymphoblastic Leukemia Treatment Market Poised for Growth, Forecasts 2024-2030: Spotlight on Emerging Therapies and Comprehensive Vendor Analysis
January 24, 2024 08:49 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Acute Lymphoblastic Leukemia Treatment Market (ALL) by Types of Cell (B-cell ALL, Philadelphia chromosome: Positive (Ph+) and negative (Ph-),...
Global CAR T-Cell Therapy Research Report 2023: Market Poised for Substantial Growth by 2030, Driven by Advancements in Cancer Treatment and Increasing Incidence Rates
January 24, 2024 04:13 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global CAR T-Cell Therapy Market 2030 by Drug type, Indication, Target Antigen, End-user and Region - Partner & Customer Ecosystem Competitive...
Global CAR T-Cell Therapy Market to Surpass $15 Billion by 2030, Driven by Growing Prevalence of Multiple Myeloma and Lymphoma
December 08, 2023 08:18 ET
|
Research and Markets
Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy Market Size, Share & Trends Analysis Report by Product (Abecma, Breyanzi), By Disease Indication (Lymphoma, Leukemia, Multiple...
MesoPher as a Maintenance Treatment after Chemotherapy, 2023 Research Report: Drug Insights and Market Forecasts, 2019-2032 - Focus on 7 Major Markets
November 23, 2023 11:13 ET
|
Research and Markets
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "MesoPher Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Lerapolturev (Formerly Known as PVSRIPO) + Pembrolizumab for Glioblastoma Multiforme (GBM): Emerging Drug Insights and Market Forecast Report, 2019-2023 & 2023-2032
November 22, 2023 08:58 ET
|
Research and Markets
Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The "Lerapolturev + Pembrolizumab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering.This report...
Exploring CAR-T Therapy: A New Era in Cancer Treatment
November 14, 2023 04:48 ET
|
Research and Markets
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The "CAR-T Therapy- Pipeline Insight, 2023" drug pipelines has been added to ResearchAndMarkets.com's offering. The research report delves into several...
Cell Counting Market Analysis Report 2023-2030: Rising Prevalence of Chronic Diseases Fueling Global Growth
October 25, 2023 07:18 ET
|
Research and Markets
Dublin, Oct. 25, 2023 (GLOBE NEWSWIRE) -- The "Cell Counting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories), By Application (Complete Blood...
Analysis of the Cell Therapy Technologies Industry, 2023-2028: Increasing Partnerships for the Development of Cell Therapies, Emerging Asian Markets
August 30, 2023 06:03 ET
|
Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's offering. The global landscape of cell...
Rising Prevalence of Acute Lymphocytic Leukemia Drives T-Cell Therapy Market: With Johnson & Johnson, AbbVie, Amgen, Novartis, Sorrento, Pfizer Dominating
August 21, 2023 07:23 ET
|
Research and Markets
Dublin, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The "Global T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication...
Emerging Trends in Acute Lymphoblastic Leukemia Treatment Market - New Report Reveals Forecast 2023-2030
August 16, 2023 06:03 ET
|
Research and Markets
Dublin, Aug. 16, 2023 (GLOBE NEWSWIRE) -- The "Global Acute Lymphoblastic Leukemia Treatment Market by Types of Cell, Therapy, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...